The role of PLK1 in prostate cancer
PLK1在前列腺癌中的作用
基本信息
- 批准号:9889905
- 负责人:
- 金额:$ 34.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2022-09-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmericanAnimal ModelApoptosisApplications GrantsAttentionBiochemicalBiological ModelsCancer EtiologyCancer PatientCancer PrognosisCell CycleCell divisionCellular MorphologyCessation of lifeClinicalCytokinesisDataDevelopmentDown-RegulationEpithelialEpithelial CellsEpitheliumEventFibroblastsGeneticHumanIn VitroKnowledgeLinkMalignant NeoplasmsMalignant neoplasm of prostateMesenchymalMetastatic Prostate CancerMitosisMitoticMolecularMusNeoplasm MetastasisOncogenicOrganPLK1 genePTEN genePhosphotransferasesPlayPopulationPreventivePropertyProstateProtein-Serine-Threonine KinasesProto-OncogenesRegulationRoleSeriesSignal TransductionTestingTherapeuticTransgenesTransgenic MiceTransgenic ModelTreatment ProtocolsWorkXenograft procedureanti-cancerbasecancer cellcancer initiationcancer typecastration resistant prostate cancercell motilitydesignepithelial to mesenchymal transitionexperimental studyin vivomenmetaplastic cell transformationmouse modelnoveloverexpressionprostate cancer cellprostate cancer cell lineprostate cancer modelprostate carcinogenesispublic health relevancestandard caretreatment optimizationtumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Mammalian polo-like kinase 1 (PLK1), a major kinase with pivotal roles in multiple aspects of cell division, is closely associated with human cancer development and is frequently overexpressed in various cancers, including prostate cancer (PCa). PLK1 has been postulated to be a proto-oncogene; however, direct evidence to support this notion is still lacking, in part, due to the lack of appropriate animal models. The overall gol of this grant proposal is to delineate the oncogenic roles of PLK1 overexpression in PCa development and metastasis. The hypothesis being tested is that PLK1 functions as a proto-oncogene during PCa initiation, progression, and metastatic dissemination. Our 2 specific aims are: 1) to define the role of PLK1 overexpression in PCa development using our recently established prostate-specific Plk1 transgenic mouse model; and 2) to determine the role of PLK1 overexpression in PCa dissemination by elucidating the molecular mechanisms underlying PLK1-induced epithelial-mesenchymal transition and PCa-cell invasion and defining the pro-metastatic properties of PLK1 using xenograft PCa models and the Plk1 transgenic mouse model. The findings of this work will provide the first in vivo evidence that PLK1 functions as a proto-oncogene in PCa. Furthermore, the results are anticipated to uncover a novel function of PLK1 that goes beyond its canonical role, and to define the oncogenic roles of PLK1 during PCa initiation, progression, and metastatic dissemination. The knowledge gained from this proposed study will fundamentally advance our understanding of the oncogenic functions of PLK1 and the molecular basis of PCa development and metastatic dissemination, which have the potential to facilitate optimization of treatment regimens targeting PLK1 signaling to significantly enhance anticancer efficacy. Furthermore, the ideas behind this proposal may be generalizable to many other cancers since preliminary clinical evidence suggests that PLK1 is involved in the development of several other human cancers.
描述(由申请人提供):哺乳动物 Polo 样激酶 1 (PLK1) 是一种在细胞分裂的多个方面发挥关键作用的主要激酶,与人类癌症的发展密切相关,并且在各种癌症中经常过度表达,包括前列腺癌 (PCa) ). PLK1 被认为是一种原癌基因;然而,仍然缺乏支持这一观点的直接证据,部分原因是缺乏适当的动物模型。描述 PLK1 过度表达在 PCa 发展和转移中的致癌作用 正在测试的假设是 PLK1 在 PCa 起始、进展和转移扩散过程中发挥原癌基因的作用。使用我们最近建立的前列腺特异性 Plk1 转基因小鼠模型来确定 PLK1 在 PCa 发育中的过度表达;2) 通过以下方法确定 PLK1 过度表达在 PCa 传播中的作用;阐明 PLK1 诱导的上皮间质转化和 PCa 细胞侵袭的分子机制,并使用异种移植 PCa 模型和 Plk1 转基因小鼠模型定义 PLK1 的促转移特性。这项工作的结果将提供第一个体内证据: PLK1 在 PCa 中充当原癌基因,此外,预计结果将揭示 PLK1 超越其典型作用的新功能,并定义其功能。 PLK1 在 PCa 起始、进展和转移扩散过程中的致癌作用从这项拟议研究中获得的知识将从根本上增进我们对 PLK1 致癌功能以及 PCa 发展和转移扩散的分子基础的理解,这有可能促进优化。此外,该提议背后的想法可能适用于许多其他癌症,因为初步临床证据表明 PLK1 参与了其他几种人类癌症的发展。癌症。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.
- DOI:10.3390/cancers9100131
- 发表时间:2017-09-27
- 期刊:
- 影响因子:5.2
- 作者:Fu Z;Wen D
- 通讯作者:Wen D
The dark side of PLK1: Implications for cancer and genomic instability.
- DOI:10.18632/oncotarget.28456
- 发表时间:2023-06-27
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors.
- DOI:10.3390/cells12091344
- 发表时间:2023-05-08
- 期刊:
- 影响因子:6
- 作者:Moore XTR;Gheghiani L;Fu Z
- 通讯作者:Fu Z
SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function.
SUMO 化促进 Polo 样激酶 1 的核输入和稳定,以支持其有丝分裂功能。
- DOI:10.1016/j.celrep.2017.10.085
- 发表时间:2017
- 期刊:
- 影响因子:8.8
- 作者:Wen,Donghua;Wu,Jianguo;Wang,Lei;Fu,Zheng
- 通讯作者:Fu,Zheng
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHENG FU其他文献
ZHENG FU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHENG FU', 18)}}的其他基金
Define the oncogenic role of Plk1 during hepatocellular carcinoma development using a genetically modified mouse model
使用转基因小鼠模型定义 Plk1 在肝细胞癌发展过程中的致癌作用
- 批准号:
10729603 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
相似海外基金
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Sleep-Wake Cycles of Individuals with Inflammatory Bowel Disease
炎症性肠病患者的睡眠-觉醒周期
- 批准号:
10604701 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
- 批准号:
10603708 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别: